Quick Answer
NOVAVAX INC reported Net Income Loss of $440.30 million for the year ending 2025.
- NOVAVAX INC showed an increase of +334.8% in Net Income Loss from 2024 to 2025.
- This data is from NOVAVAX INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$15.30 million | Q4 2013: -$14.05 million | Q1 2014: -$13.81 million | Q2 2014: -$17.86 million | Q3 2014: -$19.73 million | Q4 2014: -$31.55 million | Q1 2015: -$24.37 million | Q2 2015: -$20.64 million | Q3 2015: -$33.12 million | Q4 2015: -$78.81 million | Q1 2016: -$77.25 million | Q2 2016: -$79.35 million | Q3 2016: -$66.25 million | Q4 2016: -$57.11 million | Q1 2017: -$43.85 million | Q2 2017: -$44.47 million | Q3 2017: -$44.61 million | Q4 2017: -$50.84 million | Q1 2018: -$46.35 million | Q2 2018: -$44.49 million | Q3 2018: -$44.57 million | Q4 2018: -$49.33 million | Q1 2019: -$43.22 million | Q2 2019: -$39.60 million | Q3 2019: -$18.04 million | Q4 2019: -$31.83 million | Q1 2020: -$25.86 million | Q2 2020: -$17.52 million | Q3 2020: -$197.31 million | Q1 2021: -$222.72 million | Q2 2021: -$352.32 million | Q3 2021: -$322.43 million | Q1 2022: $203.41 million | Q2 2022: -$510.49 million | Q3 2022: -$168.61 million | Q1 2023: -$293.91 million | Q2 2023: $58.01 million | Q3 2023: -$130.78 million | Q1 2024: -$147.55 million | Q2 2024: $162.38 million | Q3 2024: -$121.30 million | Q1 2025: $518.65 million | Q2 2025: $106.51 million | Q3 2025: -$202.38 million.
- Over the full 17 years of available data (2009 to 2025), NOVAVAX INC's Net Income Loss has grown by 1,191.3%.
- Historical annual values: Fiscal year 2025: $440.30 million | Fiscal year 2024: -$187.50 million | Fiscal year 2023: -$545.06 million | Fiscal year 2022: -$657.94 million | Fiscal year 2021: -$1.74 billion | Fiscal year 2020: -$418.26 million | Fiscal year 2019: -$132.69 million | Fiscal year 2018: -$184.75 million | Fiscal year 2017: -$183.77 million | Fiscal year 2016: -$279.97 million | Fiscal year 2015: -$156.94 million | Fiscal year 2014: -$82.95 million | Fiscal year 2013: -$51.98 million | Fiscal year 2012: -$28.51 million | Fiscal year 2011: -$19.36 million | Fiscal year 2010: -$35.71 million | Fiscal year 2009: -$40.35 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: